Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in Severe Burns
NCT06968559Phase 3Recruiting
- Sponsor
- CHU de Nantes
- Start
- Nov 2025
- Primary completion
- Feb 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in burn injury, sponsored by CHU de Nantes. Started Nov 2025; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT06968559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06968559.